Skip to content

Immersive Virtual Reality for Stroke Motor Rehabilitation

The Use of Immersive Virtual Reality for Upper Limb Neurorehabilitation in Stroke Survivors

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03094650
Enrollment
10
Registered
2017-03-29
Start date
2015-02-28
Completion date
2015-11-30
Last updated
2017-03-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Stroke, Motor Disorders

Keywords

stroke, neurorehabilitation, virtual reality, rehabilitation dose, motor rehabilitation

Brief summary

The present study aims at investigating (i) the feasibility in chronic stroke of using a dedicated virtual reality (VR) based system that embeds real-time 3D motion capture and embodied visual feedback to deliver functional exercises designed for training of impaired upper limb motor skills, (ii) whether chronic stroke survivors improve in functional outcomes in the upper limb when exposed to intensive VR-based therapy, and (iii) safety and tolerance to such a technology. The investigators hypothesize that intensive VR-based rehabilitation may lead to high rehabilitation doses and functional improvement in chronic stroke.

Interventions

DEVICEMindMotion PRO

Patients will receive five weeks of therapy with 2 sessions (minimum) per week lasting for 45-60 minutes each minimum. The training sessions are based on the MindMotion PRO's virtual reality exercises.

Sponsors

Ecole Polytechnique Fédérale de Lausanne
CollaboratorOTHER
Clinique Romande de Readaptation
CollaboratorNETWORK
Mindmaze SA
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Ischemic or hemorrhagic minor-to-moderate (0\<NIHSS\<16) stroke with hemiparesis and experiencing arm motor difficulties * At least 6 months after stroke incident * Maximum 4 on the Medical Research Council Scale (MRCS) for shoulder elevation and elbow flexion/extension * 18 years and older * First ever stroke

Exclusion criteria

* Participating in another movement treatment study at the time of the present study * Severe cognitive impairment (Mini Mental Status Examination score \< 18 points) * Orthopedic impairment or visual disorders limiting the treatment * Unable to give informed consent form * Risk of epileptic seizures

Design outcomes

Primary

MeasureTime frameDescription
Rehabilitation dose: goal-directed movements (i.e. number of intended movements to achieve a task)5 weeksRehabilitation dose: goal-directed movements (i.e. number of intended movements to achieve a task)
Training intensity: number of goal-directed movements per minute of effective training time.5 weeksTraining intensity: number of goal-directed movements per minute of effective training time.
Change in Upper limb function assessed with Fugl-Meyer Assessment for Upper Extremity (FMA-UE)At baseline, 5 weeks (post intervention) and 9 weeks (follow-up)Fugl-Meyer Assessment for Upper Extremity (FMA-UE)

Secondary

MeasureTime frameDescription
Change in Visual Analog Scale (VAS) for PainAt baseline, 5 weeks (post intervention) and 9 weeks (follow-up)
Change in Functional Independence Measure (FIM)At baseline, 5 weeks (post intervention) and 9 weeks (follow-up)
Safety and Acceptance of Technology assessed with a questionnaire5 weeksParticipants will answer a questionnaire to evaluate following aspects: * Tolerance to VR intervention * Adverse event monitoring * Self-evaluation * Acceptance of technology * Motivation
Change in kinematic metrics/goniometry (active range of motion).At baseline, 5 weeks (post intervention) and 9 weeks (follow-up)
Change in Modified Medical Research Council Scale (mMRCS)At baseline, 5 weeks (post intervention) and 9 weeks (follow-up)

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 25, 2026